The Trust Premium
A small green icon on a granola bar wrapper shouldn't be worth 59 cents. Yet in a 2023 study across six Boston-area grocery stores, shoppers paid exactly that premium for products bearing the FDA's proposed "healthy" label compared to identical products without it, according to research led by Oregon State University and Tufts University. The label didn't make the food more nutritious. It didn't educate consumers about fiber content or added sugars. It simply signaled that a government agency had evaluated the product and deemed it worthy of endorsement.
What makes this premium fascinating isn't that it exists. Consumers have long paid more for labeled foods, as prior research on the USDA's "organic" certification confirms, per the study published in Food Quality and Preference. What's remarkable is how precisely the FDA label's power mapped onto a single variable that had nothing to do with nutrition: whether shoppers trusted the government. The label worked exactly as designed, but only for Americans who believed in the institution behind it.
This isn't a story about food. It's a story about institutional credibility functioning as currency in the marketplace, and what happens when that currency becomes as unevenly distributed as income itself.
The Mechanism Behind the Icon
In 2024, the FDA updated its definition of "healthy" for food packaging for the first time since 1992, aligning it with current nutrition science and federal dietary guidance, according to the agency. The 32-year gap mattered. An entire generation of nutrition research had accumulated, shifting understanding of fats, whole grains, and added sugars. The old definition had become a relic, and the FDA knew it needed to rebuild credibility through scientific rigor.
The proposed label icon itself remains under approval, but researchers Katherine Fuller and Sean Cash wanted to understand whether government endorsement would actually move consumer behavior when it arrived. So they designed an experiment with real stakes: 267 shoppers received $5 in cash they could spend on actual products, ensuring their choices had economic consequences rather than being purely hypothetical, per the study methodology.
Participants viewed 15 real-world snack products, first without any health labels, then with either generic healthy icons or the FDA-endorsed version, according to the research design. The pattern emerged immediately. Consumers were more likely to choose healthy snacks over unhealthy options when products carried health labels, as the researchers found. But only the FDA label produced a statistically significant effect compared to generic alternatives.
The difference wasn't nutritional literacy. Each participant completed surveys measuring their knowledge of healthy food options alongside their demographics and trust levels, according to the study protocol. What separated those who responded to the FDA label from those who didn't wasn't what they knew about nutrition. It was whether they trusted the government making the claim.
When Credibility Stratifies
Labels function as signals, and policy shapes how well those signals work, as the researchers noted. The USDA's organic certification commands premium prices because decades of consistent standards built institutional credibility that consumers recognize and value, according to prior research. The FDA attempted the same credibility-building exercise with its updated "healthy" definition, grounding it in contemporary science to create a signal the market would respect.
It worked. Shoppers who reported higher levels of trust in government were significantly more responsive to the FDA-backed icon, per the study findings. For these consumers, the label translated directly into purchasing decisions and willingness to pay more. The mechanism was elegant: institutional endorsement created perceived value, and perceived value justified premium pricing. The FDA had successfully built a tool that could guide Americans toward better nutrition while allowing healthier food producers to capture higher margins.
But the same label left other shoppers unmoved. The effectiveness of the FDA's healthy icon varied with the degree to which consumers trusted the government, according to the research. This wasn't about skepticism toward nutrition science broadly. It was specifically about faith in the institution making the claim. Two shoppers could have identical nutritional knowledge, face identical product choices, and make completely different decisions based solely on whether they believed the government was a credible messenger.
The stronger effect of the FDA label reflects the role of perceived institutional credibility, as Fuller and Cash found. That sentence, buried in the research, contains the entire problem. "Perceived institutional credibility" isn't evenly distributed across America. It correlates with education, geography, political affiliation, and a dozen other demographic factors that already stratify health outcomes. The FDA had created a public health tool that functioned like luxury branding, where access to its benefits required a specific form of social capital: trust in government institutions.
The Two-Tier System
Consider what this means in practice. A family in one community sees the FDA label, trusts it, and uses it to navigate grocery store choices more effectively. They pay the 59-cent premium willingly because the institutional signal has value to them. Their children benefit from marginally better nutrition, compounded over thousands of meals. Meanwhile, a family with identical income in a different community, or with different political leanings, sees the same label and dismisses it. Not because they prefer unhealthy food, but because the messenger lacks credibility in their eyes.
The FDA built a tool that works exactly as intended, according to the study's core findings. Labels act as signals for consumers, and the government-endorsed version successfully influenced both selection and willingness to pay, per the research. By conventional public health metrics, this represents success. The agency updated outdated standards, aligned them with current science, and created a mechanism that demonstrably shifts consumer behavior toward healthier choices.
Yet that success is conditional in ways that expose uncomfortable truths about American society in 2026. Public health infrastructure traditionally aimed for universal reach. Vaccination campaigns, food safety standards, and nutrition guidelines were designed to protect everyone regardless of their political beliefs or trust in government. The mechanisms worked invisibly, embedded in systems that didn't require individual faith to function.
A label is different. It requires active interpretation by consumers who must decide whether to believe the institution behind it. When that belief splits along demographic and political lines, a public health tool becomes a sorting mechanism. Those who trust receive guidance and are willing to pay for products that meet government standards. Those who don't trust are left to navigate nutrition claims without institutional support, vulnerable to whatever marketing messages food manufacturers choose to deploy.
The Credibility Problem
The researchers designed their study to isolate variables carefully. They confirmed that the trust gap wasn't actually a knowledge gap, according to their survey data. Participants across the trust spectrum had similar baseline understanding of what constitutes healthy food. The FDA label didn't work by educating people. It worked by leveraging institutional authority to cut through the noise of competing nutrition claims in the marketplace.
But authority only functions when it's recognized. The same green icon that guides one shopper's choices is invisible to another, not because of different nutritional needs or preferences, but because of different relationships to government institutions. This creates a feedback loop. Communities with higher institutional trust gain access to better nutritional guidance, potentially improving health outcomes, which might reinforce trust in government health agencies. Communities with lower trust miss those benefits, potentially widening health disparities, which might further erode confidence in public health institutions.
The FDA's 2024 definition update was technically sound, consistent with nutrition science and federal dietary guidance, according to the agency's own standards. The researchers proved the label mechanism works in the marketplace. Yet the system's effectiveness is entirely dependent on a resource that has become scarce and unevenly distributed: faith that government institutions act in the public interest.
What happens to public health when the public splits on whether to trust public institutions? The Boston study offers an answer, and it's not reassuring. We get health infrastructure that functions like premium branding, where institutional credibility becomes the price of admission. The FDA created a tool that could help millions of Americans make better food choices. But it only helps those who believe in the institution offering the help. For everyone else, the label is just another icon in the visual clutter of the grocery aisle, signifying nothing, commanding no premium, changing no behavior.
The 59-cent difference between labeled and unlabeled granola bars measures more than willingness to pay for perceived health benefits. It measures the market value of institutional trust, and reveals that in America today, some people can afford that trust while others cannot. Not in dollars, but in belief. The FDA built a system that works. The question is whether it works for a country that no longer agrees on which systems deserve to work at all.